BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10944374)

  • 1. Determination of erythromycin and related substances in enteric-coated tablet formulations by reversed-phase liquid chromatography.
    Wardrop J; Ficker D; Franklin S; Gorski RJ
    J Pharm Sci; 2000 Sep; 89(9):1097-105. PubMed ID: 10944374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved high-pressure liquid chromatographic method for the analysis of erythromycin in solid dosage forms.
    Tsuji K; Kane MP
    J Pharm Sci; 1982 Oct; 71(10):1160-4. PubMed ID: 7143216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an enhanced separation of erythromycin and its related substances by liquid chromatography.
    Deubel A; Holzgrabe U
    J Pharm Biomed Anal; 2007 Jan; 43(2):493-8. PubMed ID: 16935448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a new HPLC method for determination of lamotrigine and related compounds in tablet formulations.
    Emami J; Ghassami N; Ahmadi F
    J Pharm Biomed Anal; 2006 Mar; 40(4):999-1005. PubMed ID: 16176866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatography of erythromycin propionyl ester and erythromycin base in biological fluids.
    Stubbs C; Kanfer I
    J Chromatogr; 1988 May; 427(1):93-101. PubMed ID: 3410906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of erythromycin in serum and urine by high-performance liquid chromatography with ultraviolet detection.
    Stubbs C; Haigh JM; Kanfer I
    J Pharm Sci; 1985 Oct; 74(10):1126-8. PubMed ID: 4078714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
    Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
    J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic determination of erythromycin.
    Tsuji K; Goetz JF
    J Chromatogr; 1978 Jan; 147():359-67. PubMed ID: 621254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of erythromycin by reversed-phase liquid chromatography using column-switching.
    Cachet T; de Turck K; Roets E; Hoogmartens J
    J Pharm Biomed Anal; 1991; 9(7):547-55. PubMed ID: 1817675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of oral suspensions containing sulfonamides in combination with erythromycin ethylsuccinate.
    Elrod L; Cox RD; Plasz AC
    J Pharm Sci; 1982 Feb; 71(2):161-6. PubMed ID: 6977637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation.
    Mostafavi A; Abedi G; Jamshidi A; Afzali D; Talebi M
    Talanta; 2009 Feb; 77(4):1415-9. PubMed ID: 19084658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reversed-phase high-performance liquid chromatographic method for the determination and identification of clarithromycin as the drug substance and in various dosage forms.
    Morgan DK; Brown DM; Rotsch TD; Plasz AC
    J Pharm Biomed Anal; 1991; 9(3):261-9. PubMed ID: 1831386
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitation of buclizine hydrochloride in pharmaceutical formulations and human serum by RP-HPLC.
    Arayne MS; Sultana N; Siddiqui FA
    Pak J Pharm Sci; 2006 Oct; 19(4):326-9. PubMed ID: 17105713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of liquid chromatographic and ultraviolet derivative spectrophotometric methods for determination of epinastine hydrochloride in coated tablets.
    Ghisleni DD; Steppe M; Schapoval EE
    J AOAC Int; 2007; 90(5):1266-71. PubMed ID: 17955971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEVELOPMENT AND VALIDATION OF THE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR THE QUANTITATIVE DETERMINATION OF ERYTHROMYCIN IN DERMO-PREPARATIONS.
    Hortolomei M; Ochiuz L; Popovici I; Timofte D; Petrescu DC; Ghiciuc CM
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1174-9. PubMed ID: 26793866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of Escitalopram Oxalate and L-Methylfolate in Tablet by Spectrophotometric and Reverse Phase High-Performance Liquid Chromatographic Methods.
    Sheladia S; Patel B
    J Chromatogr Sci; 2017 May; 55(5):550-555. PubMed ID: 28203815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of diclofenac sodium and related compounds in raw materials and formulations.
    Beaulieu N; Lovering EG; Lefrançois J; Ong H
    J Assoc Off Anal Chem; 1990; 73(5):698-701. PubMed ID: 2272992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a stability indicating HPLC method for organic impurities of erythromycin stearate tablets.
    Jeelani S; Soukhova N
    J Pharm Biomed Anal; 2021 Feb; 195():113858. PubMed ID: 33388642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preparation of capsaicin-chitosan microspheres (CCMS) enteric coated tablets.
    Chen J; Huang GD; Tan SR; Guo J; Su ZQ
    Int J Mol Sci; 2013 Dec; 14(12):24305-19. PubMed ID: 24351818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of aspirin and salicylic acid in bulk aspirin and in plain, buffered, and enteric-coated tablets by high-pressure liquid chromatography with UV and fluorescence detectors.
    Kirchhoefer RD
    J Pharm Sci; 1980 Oct; 69(10):1188-91. PubMed ID: 7420289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.